Max Robotics — Global Service Robot Directory + US Certification

About

Scott E. Regenbogen is a leading colorectal surgeon and health services researcher whose work has fundamentally shaped our understanding of minimally invasive surgery for colorectal cancer. His research focuses on the comparative effectiveness of laparoscopic and robotic surgical approaches, with a particular emphasis on real-world outcomes, cost-effectiveness, and long-term survival. Regenbogen’s landmark 2015 population-based study comparing laparoscopic and robotic colorectal outcomes has been cited over 100 times, providing critical evidence on the safety and efficacy of these techniques. His work on the cost of conversion in robotic surgery (81 citations) and perioperative outcomes among Medicare beneficiaries (60 citations) has informed surgical decision-making and health policy. Notably, his 2024 study on surgical approaches and margin status in total mesorectal excision for rectal cancer, along with his 2025 instrumental variable analysis examining long-term survival after colorectal cancer surgery, represent cutting-edge methodological contributions. Through rigorous population-level analyses, Regenbogen has helped surgeons and patients navigate the rapidly evolving landscape of minimally invasive colorectal surgery, balancing innovation with evidence-based practice.